Moderna (MRNA) Tax Rate (2018 - 2026)
Moderna's (MRNA) quarterly Tax Rate came in at 1.96% in Q2 2026, down 110.0% year-over-year from 19.56% in Q2 2025, and down 189.87% quarter-over-quarter from 0.67% in Q1 2026.
Powered by 
Analysis
Moderna (MRNA) Tax Rate (2018 - 2026) Analysis & Trends
Moderna (MRNA) has reported Tax Rate for 9 consecutive years, with 1.96% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Rate fell 110.0% year-over-year to 1.96% in Q2 2026; TTM through Jun 2026 was 2.07%, a 350.0% decrease from a year earlier, with the FY2025 full-year figure at 1.95%, down 323.0% from the prior year.
- Tax Rate was 1.96% for Q2 2026 at Moderna, down from 0.67% in the prior quarter.
- Over five years, Tax Rate peaked at 125.9% in Q1 2023 and troughed at 210.0% in Q4 2023.
- A 5-year average of 4.11% and a median of 0.67% in 2026 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate plunged 22148 bps in 2023 and surged 21541 bps in 2024, its largest moves.
- Over 5 years, Tax Rate stood at 11.48% in 2022, then slumped by 1929 bps to 210.0% in 2023, then jumped by 103 bps to 5.41% in 2024, then plunged by 163 bps to 3.38% in 2025, then soared by 42 bps to 1.96% in 2026.
- The last three Tax Rate figures came in at 1.96% (Q2 2026), 0.67% (Q1 2026), and 3.38% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 26.36% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -16.71% |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn | -4.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.96% |
| Mar 31, 2026 | -0.67% |
| Dec 31, 2025 | -3.38% |
| Sep 30, 2025 | -6.95% |
| Jun 30, 2025 | -0.86% |
| Mar 31, 2025 | -0.73% |
| Dec 31, 2024 | 5.41% |
| Sep 30, 2024 | 38.10% |
| Mar 31, 2024 | -0.86% |
| Dec 31, 2023 | -210.00% |
| Sep 30, 2023 | -85.39% |
| Jun 30, 2023 | 21.10% |
| Mar 31, 2023 | 125.90% |
| Dec 31, 2022 | 11.48% |
| Sep 30, 2022 | 14.30% |
| Jun 30, 2022 | 11.20% |
| Mar 31, 2022 | 13.53% |
| Dec 31, 2021 | 10.02% |
| Sep 30, 2021 | 6.17% |
| Jun 30, 2021 | 9.24% |